ReviR Therapeutics Receives Strategic Investment from CureCMT to Advance a First-of-its-Kind Precision Medicine Platform for CMT

ReviR Therapeutics today announced a strategic investment from CureCMT to support the launch of a precision medicine platform for Charcot-Marie-Tooth disease (CMT). The platform will combine isogenic ...
Pharm Exec

ReviR Therapeutics Partners with Kennedy’s Disease Association for New Molecule Development

The two companies will work to develop treatments for SBMA. ReviR Therapeutics is partnering with Kennedy’s Disease Association to advance treatments for spinal and bulbar muscular atrophy (SBMA). 1 ...
Morningstar

ReviR Therapeutics Announces First Participant Dosed in Phase 1 Study and Secures CDE Clearance for Two Orphan Indications in China, Supporting Future U.S. Expansion Strategy

Milestone marks the first clinical program for Charcot-Marie-Tooth disease and Vanishing White Matter disease. SAN FRANCISCO and SHANGHAI, March 2, 2026 /PRNewswire/ -- ReviR Therapeutics, a ...
Medindia

ReviR Therapeutics Raises $30 Million Series A Financing to Advance its Proprietary Oral Genetic Medicines for Multiple CNS Disorders

These funds will be used to further augment ReviR's AI-driven drug discovery VoyageR platform, which will be leveraged to advance proprietary chemical matter for novel and undruggable targets and to ...
Yahoo Finance

Revir Technologies and Tyler Technologies Partner on Digital Evidence

"We know the tsunami of digital evidence is a challenge for our clients and true to our culture, we are focused on solving their pain points. Revir helps Tyler deliver for our clients and their ...
Infosecurity-magazine.com

Revir's Ride not a Derby Winner

Since new Mac-specific malware is pretty rare, I suppose I can't really ignore the malware that most AV companies are calling Revir.A (the dropper and downloader) and Imuler.A (the backdoor that ...
Pharm Exec

ReviR Therapeutics Announces Funding Haul for Oral Genetic Treatments

The company plans to develop these treatments using it’s AI-powered platform. ReviR Therapeutics announced that it has secured $30 million in Series A financing, which will be used to augment the ...
CNET

Imuler/Revir Trojan for OS X resurfaces

The malware scene in OS X is minimal when compared with other operating systems, but it is being developed at a snail's pace. Topher, an avid Mac user for the past 15 years, has been a contributing ...
manilatimes

ReviR Therapeutics and Kennedy's Disease Association Partner to Advance Treatment for Rare Neuromuscular Disorder

BRISBANE, Calif., Nov. 26, 2024 /PRNewswire/ -- ReviR Therapeutics, a pioneering biotechnology company focused on developing novel small molecule RNA modulators for neurogenetic diseases, announced a ...
CNET

Revir malware for OS X undergoes revision

Not unexpectedly, a variant of the Revir Trojan for OS X that was found a week or two ago has been found. Topher, an avid Mac user for the past 15 years, has been a contributing author to MacFixIt ...
Yahoo Finance

ReviR Therapeutics Receives Strategic Investment from CureCMT to Advance a First-of-its-Kind Precision Medicine Platform for CMT

An isogenic iPSC and AI-enabled disease modeling platform spanning multiple genetically defined CMT subtypes will be established to support patient stratification, accelerate RTX-117 development, and ...